BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanda G, Hersey M, Hempel B, Xi ZX, Newman AH. Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder. Curr Opin Pharmacol 2021;56:13-21. [PMID: 32927246 DOI: 10.1016/j.coph.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hempel B, Xi ZX. Mitochondrial Clk1-iron-DAT regulation pathway: a possible new therapeutic target for methamphetamine use disorder. Acta Pharmacol Sin 2021. [PMID: 34873315 DOI: 10.1038/s41401-021-00821-2] [Reference Citation Analysis]
2 Cocco E, Fadda P. Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil. Exp Neurol 2021;347:113906. [PMID: 34710403 DOI: 10.1016/j.expneurol.2021.113906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Lee KH, Fant AD, Guo J, Guan A, Jung J, Kudaibergenova M, Miranda WE, Ku T, Cao J, Wacker S, Duff HJ, Newman AH, Noskov SY, Shi L. Toward Reducing hERG Affinities for DAT Inhibitors with a Combined Machine Learning and Molecular Modeling Approach. J Chem Inf Model 2021;61:4266-79. [PMID: 34420294 DOI: 10.1021/acs.jcim.1c00856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hersey M, Bacon AK, Bailey LG, Coggiano MA, Newman AH, Leggio L, Tanda G. Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap? Front Neurosci 2021;15:656475. [PMID: 34121988 DOI: 10.3389/fnins.2021.656475] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Korsten P, Piantoni S. Improvement of lupus-associated fatigue with modafinil: Report of two cases. Lupus 2021;30:1013-6. [PMID: 33588615 DOI: 10.1177/0961203321995252] [Reference Citation Analysis]